Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
NCT03985644 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-06-14
Summary
Liver transplantation is an optimal radical therapy for selected patients with hepatocellular carcinoma. Hangzhou criteria could safely and effectively expand Milan criteria with expanded population and comparable survival. The purpose of this study was to evaluate the Hangzhou criteria in a multi-center cohort.
Conditions
- HCC
- Liver Transplantation
Sponsors & Collaborators
-
Zhejiang University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-31
- Primary Completion
- 2019-12-31
- Completion
- 2020-12-31
More Related Trials
-
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
NCT05155189 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)
NCT06928415 ·Status: NOT_YET_RECRUITING
-
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
NCT03983967 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria
NCT04069416 ·Status: COMPLETED
-
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
NCT04237740 ·Status: UNKNOWN ·Phase: PHASE3
-
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
NCT04415567 ·Status: COMPLETED
-
Lenvatinib Therapy in HCC Patients After LDLT
NCT05572528 ·Status: RECRUITING
-
A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer
NCT04309747 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
NCT01055743 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
NCT05171335 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy
NCT03851913 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
NCT05352204 ·Status: COMPLETED
-
The Efficacy of Sequential RT After Triple Therapy for uHCC
NCT07052448 ·Status: ENROLLING_BY_INVITATION
-
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
NCT03668158 ·Status: UNKNOWN
-
TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
NCT03899415 ·Status: UNKNOWN ·Phase: PHASE1
-
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma
NCT06365034 ·Status: RECRUITING
-
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
NCT02959151 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
NCT07310836 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure
NCT01844063 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma
NCT05312216 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC
NCT04241523 ·Status: UNKNOWN ·Phase: PHASE2
-
Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma
NCT04195503 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
NCT04642547 ·Status: COMPLETED ·Phase: NA
-
Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy
NCT05057104 ·Status: UNKNOWN
-
Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer
NCT05383066 ·Status: UNKNOWN